Androstenedione as a potential predictor of ovarian response in assisted reproductive technology programs
Aim. To assess the possibility of using androstenedione levels in blood serum and follicular fluid to predict ovarian response in assisted reproductive technology programs and to conduct a comparative analysis of the results obtained by 2 methods chemiluminescent immunoassay (CLIA) and high-performa...
Saved in:
Main Authors: | Anna G. Burduli (Author), Natalia A. Kitsilovskaya (Author), Yuliya V. Sukhova (Author), Irina A. Vedikhina (Author), Tatiana Yu. Ivanets (Author), Vitaliy V. Chagovets (Author), Nataliia L. Starodubtseva (Author), Vladimir E. Frankevich (Author) |
---|---|
Format: | Book |
Published: |
IP Berlin A.V.,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Follicular fluid and assisted reproductive technology programs outcomes (literature review)
by: Anna G. Burduli, et al.
Published: (2020) -
Differential diagnosis of benign and malignant ovarian tumors based on the blood metabolome
by: Maria V. Iurova, et al.
Published: (2024) -
Diagnosis of Ia-Ic stages of serous high-grade ovarian cancerby the lipid profile of blood serum
by: Mariia V. Iurova, et al.
Published: (2021) -
Androstenedione response to recombinant human FSH is the most valid predictor of the number of selected follicles in polycystic ovarian syndrome: (a case-control study)
by: Eser Sefik Ozyurek, et al.
Published: (2017) -
Infantile virilisation caused by an androstenedione-producing adrenal adenoma
by: Oliver McCallion, et al.
Published: (2019)